In 2014, the State of Hawai‘i sued the manufacturers of the antiplatelet medication Plavix in state court for violating Hawaii’s unfair or deceptive trade practices act, chapter 480, Hawai‘i Revised Statutes (“UDAP”). After a four-week, virtual, non-jury trial concluded in November 2020, the Hawai‘i trial court entered judgment awarding more than $834 million in civil…